Filing Flows › Medinotec (MDNC) › Q1 FY26
Medinotec (MDNC) Q1 FY26 earnings results (first quarter fiscal 2026)
10-Q filed Jul 16, 2025
Medinotec (MDNC) reported revenue of $2.1M for the first quarter fiscal 2026 (Q1 FY26), +70% from a year earlier and -39% from the quarter before. Operating margin was 13.0%, net earnings $114K (5.3% of revenue).
Medinotec, Q1 FY26: revenue $2.1M (+70% year over year), operating margin 13.0%, net earnings $114K, operating cash flow −$759K. The chart follows the revenue to costs, profit and cash.
| Q1 FY26 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.1M | -39% | +70% |
| Gross profit | $913K | -61% | +52% |
| Operating profit | $277K | -86% | +3% |
| Net earnings | $114K | -92% | +30% |
| Operating cash flow | −$759K | -869% | — |
What changed
Revenue was $2.1M in Q1 FY26, up 70% year over year and down 39% from the previous quarter. Outside U S A Distribution Agreement Sales was the largest line at 77% of revenue. Outside U S A Distribution Agreement Sales added $1.3M year over year (up 423%), 151% of the total change. Outside U S A Internally Designed Manufactured Sales declined 58%.
Gross margin was 42.8%, down 5.2 points from a year earlier. Operating profit was $277K, a 13.0% margin (down 8.5 points year over year). Of the extra revenue versus a year earlier, 1% reached operating profit, below the 22% margin then. Operating expenses grew 92% against revenue growth of 70%. Net earnings were $114K, up 30% year over year. The effective tax rate was 56.7%.
Operating cash flow was −$759K. Non-cash charges added back $8K of depreciation and amortization. Working capital and other items used $881K.
Questions
What was Medinotec's revenue in the first quarter fiscal 2026?
Medinotec (MDNC) reported revenue of $2.1M for the first quarter fiscal 2026 (Q1 FY26), +70% from a year earlier and -39% from the quarter before.
Was Medinotec profitable in the first quarter fiscal 2026?
Operating profit was $277K (13.0% of revenue) and net earnings $114K.
Source: Medinotec 10-Q on SEC EDGAR.